Metraipolis › archive › dc_08de18afaaa3

Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy — Europe PMC PMID:41471356

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41471356
DOI: 10.3390/ph18121867
License (as archived): solo-consultazione
Archived: 2026-11-07T21:09:33.753Z
SHA-256 of the archived text: e7b50e31176cd8f745b0f22d3e683c5de0d34b959931b23a5717b385f89e7b89
Stable URL of this page: https://metraipolis.com/documento/dc_08de18afaaa3

How to cite

Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy — Europe PMC PMID:41471356 — Europe PMC (en), https://europepmc.org/article/MED/41471356 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08de18afaaa3 (Metraipolis archive dc_08de18afaaa3, sha256 e7b50e31176cd8f745b0f22d3e683c5de0d34b959931b23a5717b385f89e7b89)

BibTeX

@misc{dc08de18afaaa3,
  title = {Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy — Europe PMC PMID:41471356},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471356},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08de18afaaa3; sha256 e7b50e31176cd8f745b0f22d3e683c5de0d34b959931b23a5717b385f89e7b89},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471356. Agents can read the archived copy with the MCP tool read_document.